HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
6- N,N- bis(2,2,2- trifluoroethyl)amino- 4- trifluoromethylquinolin- 2(1H)- one
an androgen receptor modulator; structure in first source
Also Known As:
LGD 2226; LGD-2226; LGD2226
Networked:
1
relevant articles (
1
outcomes,
1
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Quinolines: 146
Quinolones: 2938
6-N,N-bis(2,2,2-trifluoroethyl)amino-4-trifluoromethylquinolin-2(1H)-one: 1
Aminoquinolines: 29
6-N,N-bis(2,2,2-trifluoroethyl)amino-4-trifluoromethylquinolin-2(1H)-one: 1
Experts
1.
Negro-Vilar, A
: 1 article (03/2002)
2.
Rosen, J
: 1 article (03/2002)
Related Diseases
1.
Hypogonadism (Hypergonadotropic Hypogonadism)
03/01/2002 - "
In recent studies, we have used a skeletally mature orchiectomized (ORX) male rat as an animal model of male hypogonadism for assessing the efficacy of LGD2226, a nonsteroidal, non-aromatizable, and non-5alpha-reducible SARM.
"
2.
Bone Resorption
03/01/2002 - "
Biochemical markers of bone turnover revealed an early increase of bone resorption in androgen-deficient rats that was repressed in ORX animals treated with the oral SARM, LGD2226, during a 4-month treatment period.
"
Related Drugs and Biologics
1.
Biomarkers (Surrogate Marker)
2.
Androgens